A cross-border takeover thriller that not only saw corporate action but also diplomatic dealings and slugfests among bankers.
Rashtriya Janata Dal chief Lalu Prasad's controversial brother-in-law Sadhu Yadav has been given a pride of place in the publicity committee of the Congress in poll-bound Bihar.
'Rahul Gandhi is on a 3,500 km-long march. For me, kilometers do not matter'
In some Bihar constituencies, candidates named Ram are fighting each other.
As several parts of the nation remains in the grip of severe drought, a whopping 1000 litres of water was wasted for preparing a helipad for Haryana Chief Minister Manohar Lal Khattar's chopper in Ganganagar on Thursday.
Under the conditions, the firms shall submit data of ongoing clinical trials and the vaccines to be supplied for programmatic setting.Adverse event following immunisation will continue to be monitored.
Iraq can send its personnel to India for training on the conduct of polls, Natwar Singh said.
Only three seats, which were among 12 constituencies where Uttar Pradesh Chief Minister Yogi Adityanath addressed rallies, were bagged by the BJP.
What some of our political leaders were up to on Monday.
"My family reputation kept me a silent spectator, as I mutely watched the organisation I founded come to a point where it was publicly auctioned; where my family and myself have been stripped of our legacy, our finances and my personal credibility."
Singh, who took charge of EHIRC, relinquished the new position as part of new the settlement and would continue as the Managing Director of EHIRC
Hospital chain Fortis Healthcare's Rs 1,000 crore (Rs 10 billion) rights issue is likely to hit the market by October, with the firm taking fresh steps to realise the plan.
'The BJP would like to build a 'rainbow' coalition of different castes and communities buttressed by the appeal of nationalism and Hindutva.'
BJP, SP and CPI accuse Lalu's railway Budget as being discriminatory, parochial and disappointing.
'We are seeing an era where only what Modi wishes is going to happen.' 'A clear message has now been sent to others that if this fate could befall on Nitin Gadkari, then just think what could happen to lesser mortals.'
"It will be the team I choose to have with the approval of the board. It is really our call on how to run the business. Certainly, the growth will be higher and so will be the size and scale of the investments. You will see a lot more aggression in terms of leveraging opportunities for the next few years," says Ranbaxy CEO Malvinder Mohan Singh.
What were our political leaders up to on the weekend?
"After six hectic years, particularly the last four of the Bush administration, the pace has been too scorching for both systems and so much had been done", hence there is need for pause, reflection and consolidation feels Dr C Raja Mohan.
Ranbaxy Group company Fortis Healthcare Ltd on Monday said it plans to have 25 hospitals across the country in the next three years and is looking into the possibility of tapping the capital markets for expansion.
Janata Dal-United president Sharad Yadav on Wednesday visited the native village of jailed criminal-turned-politician Anand Mohan Singh, a former MP serving life sentence in a murder case, to seek blessings of his mother for the Lok Sabha polls.
The deceased personnel, Bhailal (30) and Jairam (30), were in the bomb disposal squad vehicle of the Gujarat Police had taken a halt near Nathgram Ashram on Malkhanpur road under Sirsaganj area, when a speeding truck rammed into their vehicle, Superintendent of Police Rakesh Singh said.
India's leading drug maker Ranbaxy Laboratories is likely to announce a drug discovery research tie-up with US drug manufacturer Merck soon. Ranbaxy's ongoing research collaboration with GSK also relates to the pre-clinical trial phase of the new drug, with significant milestone payment and post-commercialisation royalty possibilities. Ranbaxy's decision to de-merge its research operations was intended at having more collaborative research programmes involving foreign firms.
The 36-year-old actor had spent about eight hours at the agency's office on Wednesday as she was questioned and her statement was recorded in multiple sessions under the Prevention of Money Laundering Act (PMLA).
Continuing with its push in the US market, Ranbaxy Laboratories said on Monday it has acquired the marketing rights for 13 skincare products from Bristol-Myers Squibb Company for $26 million.
A day after Narendra Modi's long meeting with top Rashtriya Swayamsevak Sevak brass, BJP president Rajnath Singh on Sunday met senior Sangh leaders at the RSS office in New Delhi.
A photograph of Rashtriya Swayamsevak Sangh chief Mohan Bhagwat sitting with Samajwadi Party patriarch Mulayam Singh Yadav has set tongues wagging in poll-bound Uttar Pradesh, with the Congress taunting that the S in SP means the Sangh.
Chief Minister Sukhvinder Singh Sukhu said efforts are on to rescue the 300 stranded people, and they could be airlifted as the weather clears. Power and water supply has been snapped in several areas.
Why is the Congress worried about Rajnath Singh? Did the new BJP president upset the RSS's apple cart? Read on, and find out in this week's Dilli Gupshup.
Ranbaxy, one of the first Indian companies to set up a venture in China in 1993, is bullish in its operations.
Ranbaxy has completed the second phase of the clinical trial of a revolutionary anti-malarial drug that could enable it to be the nation's first pharmaceutical company to launch a New Chemical Entity globally.
Senior lawyers H S Phoolka and Himmat Singh Shergill figure in the first list of 19 candidates released by the AAP on Thursday for Punjab assembly elections.
US giant expected to bid for 65% non-promoter stake.
On Ashaji's 89th birthday on September 8, Subhash K Jha revisits some of her lesser-known classics.
Star wrestlers Bajrang Punia and Vinesh Phogat's request to train in Kyrgyzstan and Poland respectively was approved by TOPS.
What some of our leaders were up to over the weekend.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances